KEAP1 and chronic kidney disease: In conclusion, the current study identified a previously uncharacterized OGT-mediated KEAP1/NRF2 axis that influences VC in CKD settings and revealed a potential treatment strategy to prevent or treat cardiovascular complications associated with CKD.